Injectable agents for the induction of Peyronie's disease in model rats: a comparative study.
- Author:
Guang-Jun DU
1
;
Si-Yan XING
1
;
Ning WU
1
;
Tong WANG
1
;
Yue-Hui JIANG
1
;
Tao SONG
1
;
Bai-Bing YANG
1
;
Yu-Tian DAI
1
Author Information
- Publication Type:Comparative Study
- MeSH: Animals; Male; Penile Induration/drug therapy*; Rats; Transforming Growth Factor beta1/metabolism*; Disease Models, Animal; Fibrin; Penis/drug effects*; Polidocanol/administration & dosage*; Rats, Sprague-Dawley; Polyethylene Glycols/administration & dosage*; Injections
- From: Asian Journal of Andrology 2025;27(1):96-100
- CountryChina
- Language:English
- Abstract: Peyronie's disease (PD) is a disorder characterized by fibrous plaque formation in the penile tissue that leads to curvature and complications in advanced stages. In this study, we aimed to compare four injectable induction agents for the establishment of a robust rat model of PD: transforming growth factor-β1 (TGF-β1), fibrin, sodium tetradecyl sulfate (STS) combined with TGF-β1, and polidocanol (POL) combined with TGF-β1. The results showed that injection of TGF-β1 or fibrin into the tunica albuginea induced pathological endpoints without causing penile curvature. The STS + TGF-β1 combination resulted in both histological and morphological alterations, but with a high incidence of localized necrosis that led to animal death. The POL + TGF-β1 combination produced pathological changes and curvature comparable to STS + TGF-β1 and led to fewer complications. In conclusion, fibrin, STS + TGF-β1, and POL + TGF-β1 all induced PD with a certain degree of penile curvature and histological fibrosis in rats. The POL + TGF-β1 combination offered comparatively greater safety and clinical relevance and may have the greatest potential for PD research using model rats.
